VT News
Paul Sarbanes

Paul Sarbanes

Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • Lottery odds highlight the balance between the allure of big wins and the reality of low probability of success.
  • Tottenham's long-serving chairman Daniel Levy resigns, ushering in a new era for the club with a fresh leadership team.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
  • Lottery odds highlight the balance between the allure of big wins and the reality of low probability of success.
  • Tottenham's long-serving chairman Daniel Levy resigns, ushering in a new era for the club with a fresh leadership team.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Paul Sarbanes

Top Topics

Trending in U.S.

World

Sport